Cancer Research UK’s Drug Development Office (DDO) has launched a new clinical trial to treat lymphoma patients using the body’s own immune system to attack cancerous B-cells growing out of control
31 January, 2014
The Royal Society of Chemistry and Cogent have signed a Memorandum of Agreement to work in partnership to help small and medium-sized companies in the chemicals industry to recruit the best talent.
30 January, 2014
UCB has announced the global launch of its ‘Innovation Challenge’, reinforcing its role as a pioneering science-skills leader. This new online challenge seeks to find rare phenotypes - for example, people who are somehow protected from disease or possess exceptional tissue regeneration. By better understanding the molecular basis of a rare phenotype, UCB scientists hope to be able to develop new medicines for the treatment of severe diseases such as rheumatoid arthritis or multiple sclerosis.
29 January, 2014
TEMPEST (ThermoElectric Materials, Physics, Electronics and SysTems) Network to launch on 26th February 2014 in ManchesterThe Nanotechnology Knowledge Transfer Network (NanoKTN – www.nanoktn.com), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, is pleased to announce its support for the first UK Thermoelectric Network – TEMPEST, funded through the Engineering & Physical Sciences Research Council (EPSRC).
28 January, 2014
Scientists have identified a channel present in many pain detecting sensory neurons that acts as a ‘brake’, limiting spontaneous pain. It is hoped that the new research, published on 21st January in The Journal of Neuroscience, will ultimately contribute to new pain relief treatments.
21 January, 2014
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
21 January, 2014
Loughborough is the location for a 70-acre world-class science and technology park as development of a former pharmaceutical research and development site gets underway.
20 January, 2014
The first view from here of 2014 deals with aspects of the treatment of skeletal disorders, with a focus on osteoporosis
15 January, 2014
Reservoirs of pharmaceuticals could be manufactured to bind specifically to infected tissue such as cancer cells for slow, concentrated delivery of drug treatments, according to new research published in ACS Macro Letters. The findings, from the University of Copenhagen and the Institut Laue-Langevin (ILL), came as a result of neutron reflectometry studies at the world’s leading neutron source in Grenoble, France. They could provide a way to reduce dosages and the frequency of injections administered to patients undergoing a wide variety of treatments, as well as minimising side effects of over-dosing.
15 January, 2014
3D nanoSIMS project will provide high-resolution label-free imaging to see reliably, for the first time, where drugs go to in cells .
14 January, 2014
In-license Vaccine Technology for Respiratory Syncytial Virus (RSV) from Mymetics
10 January, 2014
Results published in Neuron demonstrate efficacy in preclinical mouse models of Alzheimer’s diseaseYesterday the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models1. Roche Pharma Early Research and Development (pRED) scientists found that such enhanced transfer of antibodies through the BBB was associated with a marked improvement in amyloid reduction in the brain of a mouse model of Alzheimer’s disease.
09 January, 2014
A government minister has been told that rising demand for life sciences manufacturing at one of Britain’s fastest-growing hi-tech business parks is set to herald a new building programme.
03 January, 2014
SciLifeLab have announced that The Human Protein Atlas project has reached a major milestone by releasing protein data for more than 80% of the human protein-coding genes and RNA expression data for more than 90% of the genes. The Protein Atlas has also been restructured into 4 sub-atlases, of which the largest, The Normal Tissue Atlas, now provides the first comprehensive distribution map of both protein and gene expression in the human body.
02 January, 2014